The bioequivalence of generic drugs are brand name drugs. They have the same ingredients, dosage, effectiveness and characteristics of the respective brands. They come with an added advantage of being at the lower price.
What qualifies as a generic drug cons?
To be classified a drug as a generic drug, it must be:
consists of the same active ingredients as their branded counterparts.
bioequivalence of innovative medicines.
have the same standards of quality, strength and purity of the drug innovator.
Manufactured to the same rules as those of branded drugs.
Why generic drugs are less expensive than innovator drugs?
Generics are less expensive than innovator drugs and their branded counterparts, because they involve costs less overhead. An innovative drug must be created after years of research and investment money. Innovation is, by laboratory experiments that followed caused more expenses for manufacturers of innovative medicines. Generic manufacturers do not incur these costs. You just have to produce bio-equivalent translation of the drug. No cost to determine the safety of generic drugs arise, since the equivalent brand they are already successful. Thus, generics are less expensive because the cost is only in its production.
In most cases, generic companies not to spend money on advertising either. Also rated generics are less expensive because when the patent expires, competition, balancing between different pharmaceutical companies sell more and more, to be more intense.
Generic drugs and patent
Unlike manufactured innovative medicines sold without patent protection for generic drugs and their active ingredients. You may or may not patent protection for its formulation. The whole idea of a patent is the exclusive right to sell a product or service access. Because generic drugs already on innovative medicines, it is not the issue.
An innovative drug is patented, when it is first presented. However, with the expiration of a patent, the innovator company loses its exclusive rights. It is then that a drug is created, the generic version. It is imperative that generic versions of the same formulation that are innovative medicines.
Generics may differ in appearance from their peers, as trademarks, even if they have the same active ingredients, can vary their auxiliaries.